All You Need to Know About AnaptysBio, Inc. (ANAB) Rating Upgrade to BuyZacks Investment Research • 03/30/20
Why Biotech Stocks AnaptysBio, bluebird bio, and Editas Medicine Are Sinking TodayThe Motley Fool • 03/12/20
AnaptysBio Is Due For A Bounce As It Trades Significantly Below Its Net Cash Per ShareSeeking Alpha • 11/12/19
This Biotech Stock Just Crashed 70% To Its Lowest-Ever Point — Here's WhyInvestors Business Daily • 11/08/19
AnaptysBio Reports Etokimab ATLAS Phase 2b Clinical Trial in Moderate-to-Severe Atopic Dermatitis Fails to Meet Primary EndpointGlobeNewsWire • 11/08/19
Earnings Preview: AnaptysBio, Inc. (ANAB) Q3 Earnings Expected to DeclineZacks Investment Research • 11/07/19
AnaptysBio Reports Positive Topline Data from Interim Analysis of GALLOP Phase 2 Clinical Trial of ANB019 Monotherapy in Moderate-to-Severe Generalized Pustular PsoriasisGlobeNewsWire • 09/30/19